• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up2.00% Nasdaq Up1.66%

    More On VOQP



    News & Info


    Analyst Coverage



    VioQuest Pharmaceuticals Inc. (VOQP)

    -Other OTC
    0.02 0.00(0.00%) N/A
    ProfileGet Profile for:
    VioQuest Pharmaceuticals Inc.
    180 Mount Airy Road
    Suite 102
    Basking Ridge, NJ 07920
    United States - Map
    Phone: 908-766-4455
    Website: http://www.vioquestpharm.com

    Index Membership:N/A
    Full Time Employees:3

    Business Summary 

    VioQuest Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of clinical stage drug therapies for the treatment of oncology and infectious diseases. Its lead product includes Xyfid, which is under development for the treatment and prevention of hand-foot syndrome. The company’s products also consist of VQD-002, a nucleoside analog that is in Phase I clinical trials for the treatment of cancer; and Lenocta, a small molecule inhibitor of various protein tyrosine phosphatases, which is in Phase IIa clinical trials for the treatment of melanoma, renal cell carcinoma, and other solid tumors. VioQuest Pharmaceuticals also provides chiral products, technology, and custom synthesis development services to pharmaceutical and fine chemical companies in various stages of a products’ lifecycle. The company was founded in 2000 and is headquartered in Basking Ridge, New Jersey.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on VioQuest Pharmaceuticals Inc.

    Key Executives 
    Dr. Bing Yu Ph.D.,
    Director of Global Operations
    Ms. Lisa Lindberg ,
    VP of Investor Relations and Corp. Communications
    Dr. Yaping Hong Ph.D., 60
    Sr. VP of Global Process R&D
    Mr. Mark D. Dacko , 65
    Controller and Assistant Sec.
    Dr. Michael Cannarsa Ph.D., 59
    Gen. Mang. of Chiral Quest
    Amounts are as of Dec 31, 2006 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders